July 30 (Bloomberg) -- Alexion Pharmaceuticals, the drugmaker whose blood-disease treatment is among the world’s most expensive medicines, engaged Goldman Sachs as an adviser as it prepares for a possible takeover offer from Roche, said people with knowledge of the matter. Cristina Alesci reports on Bloomberg Television's "Money Moves." (Source: Bloomberg)
This text has been automatically generated. It may not be 100% accurate.